Efficacia della somministrazione di Lamotrigina a lungo termine in soggetti con epilessia farmacoresistente

Translated title of the contribution: Effectiveness of long-term lamotrigine treatment in drug-resistant epilepsy

S. A. Musumeci, M. Elia, A. Castano, R. Ferri, S. Del Gracco, M. C. Stefanini

Research output: Contribution to journalArticle

Abstract

Eight female patients (age range 10-36 years) affected by symptomatic drug-resistant epilepsy were included in an add-on therapeutic trial with lamotrigine (200-350 mg/day). In all subjects, seizure frequency was evaluated during the two months preceding the administration of lamotrigine and during the 12 months of therapy, subdivided into 4-month periods. Furthermore, EEG during wakefulness and sleep polygraphic recordings were obtained just before the start of the treatment with lamotrigine and 3 and 12 months after. These allowed us to quantify both the interictal paroxysmal EEG activity and the ictal paroxysmal episodes. The results, showing a significant decrease of both clinical and laboratory indexes of paroxysmal activity, which became evident after the first 4 months of therapy and was maintained during the whole period of study, allow us to confirm the long- term effectiveness of lamotrigine in the treatment of drug-resistant epilepsy.

Original languageItalian
Pages (from-to)241-242
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number95-96
Publication statusPublished - 1996

Fingerprint

Electroencephalography
Therapeutics
Wakefulness
Sleep
Seizures
Stroke
Drug Resistant Epilepsy
lamotrigine

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Efficacia della somministrazione di Lamotrigina a lungo termine in soggetti con epilessia farmacoresistente. / Musumeci, S. A.; Elia, M.; Castano, A.; Ferri, R.; Del Gracco, S.; Stefanini, M. C.

In: Bollettino - Lega Italiana contro l'Epilessia, No. 95-96, 1996, p. 241-242.

Research output: Contribution to journalArticle

@article{22afb2a4ca074ebf9348165f0120f2f3,
title = "Efficacia della somministrazione di Lamotrigina a lungo termine in soggetti con epilessia farmacoresistente",
abstract = "Eight female patients (age range 10-36 years) affected by symptomatic drug-resistant epilepsy were included in an add-on therapeutic trial with lamotrigine (200-350 mg/day). In all subjects, seizure frequency was evaluated during the two months preceding the administration of lamotrigine and during the 12 months of therapy, subdivided into 4-month periods. Furthermore, EEG during wakefulness and sleep polygraphic recordings were obtained just before the start of the treatment with lamotrigine and 3 and 12 months after. These allowed us to quantify both the interictal paroxysmal EEG activity and the ictal paroxysmal episodes. The results, showing a significant decrease of both clinical and laboratory indexes of paroxysmal activity, which became evident after the first 4 months of therapy and was maintained during the whole period of study, allow us to confirm the long- term effectiveness of lamotrigine in the treatment of drug-resistant epilepsy.",
keywords = "Drug-resistant epilepsy, Lamotrigine",
author = "Musumeci, {S. A.} and M. Elia and A. Castano and R. Ferri and {Del Gracco}, S. and Stefanini, {M. C.}",
year = "1996",
language = "Italian",
pages = "241--242",
journal = "Bollettino - Lega Italiana contro l'Epilessia",
issn = "0394-560X",
publisher = "Lega Italiana contro l'Epilessia",
number = "95-96",

}

TY - JOUR

T1 - Efficacia della somministrazione di Lamotrigina a lungo termine in soggetti con epilessia farmacoresistente

AU - Musumeci, S. A.

AU - Elia, M.

AU - Castano, A.

AU - Ferri, R.

AU - Del Gracco, S.

AU - Stefanini, M. C.

PY - 1996

Y1 - 1996

N2 - Eight female patients (age range 10-36 years) affected by symptomatic drug-resistant epilepsy were included in an add-on therapeutic trial with lamotrigine (200-350 mg/day). In all subjects, seizure frequency was evaluated during the two months preceding the administration of lamotrigine and during the 12 months of therapy, subdivided into 4-month periods. Furthermore, EEG during wakefulness and sleep polygraphic recordings were obtained just before the start of the treatment with lamotrigine and 3 and 12 months after. These allowed us to quantify both the interictal paroxysmal EEG activity and the ictal paroxysmal episodes. The results, showing a significant decrease of both clinical and laboratory indexes of paroxysmal activity, which became evident after the first 4 months of therapy and was maintained during the whole period of study, allow us to confirm the long- term effectiveness of lamotrigine in the treatment of drug-resistant epilepsy.

AB - Eight female patients (age range 10-36 years) affected by symptomatic drug-resistant epilepsy were included in an add-on therapeutic trial with lamotrigine (200-350 mg/day). In all subjects, seizure frequency was evaluated during the two months preceding the administration of lamotrigine and during the 12 months of therapy, subdivided into 4-month periods. Furthermore, EEG during wakefulness and sleep polygraphic recordings were obtained just before the start of the treatment with lamotrigine and 3 and 12 months after. These allowed us to quantify both the interictal paroxysmal EEG activity and the ictal paroxysmal episodes. The results, showing a significant decrease of both clinical and laboratory indexes of paroxysmal activity, which became evident after the first 4 months of therapy and was maintained during the whole period of study, allow us to confirm the long- term effectiveness of lamotrigine in the treatment of drug-resistant epilepsy.

KW - Drug-resistant epilepsy

KW - Lamotrigine

UR - http://www.scopus.com/inward/record.url?scp=0030417105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030417105&partnerID=8YFLogxK

M3 - Articolo

SP - 241

EP - 242

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 95-96

ER -